Company / Working Capital per Share
NewAmsterdam Pharma Co N.V. Working Capital per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$16.27
FY2025
5-year range
$8.19 / $23.30
FY2022-FY2025
Trend
-22.0%
vs FY2024
Sector context
#27 of 210
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s working capital per share of $16.27 is higher than 87% of companies in the Health Care sector (FY2025). Improved from $8.19 to $16.27 over the past 2 years.
Based on SEC 10-K filings.
16.27 in FY2025 with a 3-year CAGR of -11.3%. Top quartile in the Health Care sector.
Improved from $8.19 to $16.27 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 210This company $16.27 Sector average $146.86
▼
-88.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 22.0% year-over-year.
- Ranks #27 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.27 | -22.0% |
| FY2024 | $20.86 | +154.8% |
| FY2023 | $8.19 | -64.9% |
| FY2022 | $23.30 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026